Patent Assignment
Reel/Frame 067398/0261
Security Interest
Recorded: 2024-05-13
Pages: 11
Assignor
APELLIS PHARMACEUTICALS, INC.
Executed: 2024-05-13
Assignee
SIXTH STREET LENDING PARTNERS
2100 MCKINNEY AVENUE, SUITE 1500, DALLAS, TEXAS, 75201
Covered Properties
(44)
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Application:
18/133,372 →
Publication:
US 2024/0076317
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Related Compositions and Methods
Application:
17/673,703 →
Publication:
US 2023/0091471
Dosing Regimens
Combination Therapy for C3 Inhibition
Application:
17/719,074 →
Publication:
US 2023/0009757
Dosing Regimens and Related Compositions and Methods
Application:
18/386,542 →
Publication:
US 2024/0285783
Dosing Regimens and Related Compositions and Methods
Viral Vector Therapy
Application:
17/624,755 →
Publication:
US 2022/0249706
Rnas for Complement Inhibition
Treatment of Paroxysmal Nocturnal Hemoglobinuria
Application:
17/791,194 →
Publication:
US 2023/0076527
Rnas for Complement Inhibition
Application:
17/798,339 →
Publication:
US 2023/0095695
Methods of Treating Eye Disorders
Application:
18/027,331 →
Publication:
US 2023/0381269
Genomic Editing of Complement
Application:
18/266,464 →
Publication:
US 2024/0110182
Polypeptides for Complement Inhibition
Application:
18/282,664 →
Publication:
US 2025/0145673
Genomic Editing of Complement
Application:
18/563,588 →
Publication:
US 2024/0216538
Treatment of Complement-Mediated Disorders
Application:
18/563,184 →
Publication:
US 2025/0002910
Complement Inhibition
Application:
18/573,634 →
Publication:
US 2024/0360103
Systems and Methods for Virtual Reality, Augmented Reality, and Mixed Reality Based Visual Function Assessment
Application:
18/702,594 →
Complement Inhibition
Application:
63/580,696 →
Complement Inhibition
Application:
63/622,472 →
Methods of Using Geographic Atrophy Lesion Characteristics
Application:
63/588,224 →
C3 Targeted Inhibitory Rna
Application:
63/556,773 →
Compositions and Methods for Enhancing Phagocytosis or Phagocyte Activity
Methods of Treating Age-Related Macular Degeneration by Compstatin and Analogs Thereof
A method of treating age-related macular degeneration comprising administering a compstatin analog
Methods of Selecting Compstatin Mimetics
Local Complement Inhibition for Treatment of Complement-Mediated Disorders
Compstatin Analogs for Treatment of Neuropathic Pain
Compstatin Analogs for Treatment of Neuropathic Pain
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Uses Thereof
Methods of Treating Chronic Disorders with Complement Inhibitors
Methods of Treating Chronic Disorders with Complement Inhibitors
Methods of Treating Chronic Disorders with Complement Inhibitors
Detection of High Risk Drusen
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Related Compositions and Methods
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Related Compositions and Methods
Cell-Reactive, Long-Acting, or Targeted Compstatin Analogs and Related Compositions and Methods
Dosing Regimens
Combination Therapy for C3 Inhibition
Dosing Regimens and Related Compositions and Methods
Dosing Regimens and Related Compositions and Methods
Rnas for Complement Inhibition
Patent:
11,510,939 →
Application:
16/853,732 →
Treatment of Geographic Atrophy
PCT:
PCT/US2022/043127 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 31, 2005
From: FRANCOIS, CEDRIC; DESCHATELETS, PASCAL; OLSON, PAUL; MACHIELS, ALEC
To: POTENTIA PHARMACEUTICALS, INC.
Reel/Frame 016205/0411 →
Assignment of Assignor's Interest
Jan 13, 2012
From: DESCHATELETS, PASCAL; OLSON, PAUL; FRANCOIS, CEDRIC
To: POTENTIA PHARMACEUTICALS, INC.
Reel/Frame 027527/0010 →
Assignment of Assignor's Interest
May 28, 2013
From: DESCHATELETS, PASCAL; OSLON, PAUL; FRANCOIS, CEDRIC
To: POTENTIA PHARMACEUTICALS, INC.
Reel/Frame 030495/0158 →
Corrective Assignment to Correct the Spelling of Paul Olson's Name Previously Recorded on Reel 030495 Frame 0158. Assignor(S) Hereby Confirms the Name Olson Was Incorrectly Spelled Oslon.
Jun 6, 2013
From: DESCHATELETS, PASCAL; OLSON, PAUL; FRANCOIS, CEDRIC
To: POTENTIA PHARMACEUTICALS, INC.
Reel/Frame 030600/0956 →
Assignment of Assignor's Interest
Dec 2, 2015
From: POTENTIA PHARMACEUTICALS, INC.
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 037185/0575 →
Assignment of Assignor's Interest
Jan 27, 2017
From: POTENTIA PHARMACEUTICALS, INC.
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 041099/0855 →
Assignment of Assignor's Interest
Jan 27, 2017
From: DESCHATELETS, PASCAL; OLSON, PAUL; FRANCOIS, CEDRIC
To: POTENTIA PHARMACEUTICALS, INC.
Reel/Frame 041517/0594 →
Assignment of Assignor's Interest
Oct 21, 2020
From: POTENTIA PHARMACEUTICALS, INC.
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 054174/0194 →
Assignment of Assignor's Interest
Oct 21, 2020
From: POTENTIA PHARMACEUTICALS, INC.
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 054174/0173 →
Assignment of Assignor's Interest
Feb 18, 2022
From: FRANCOIS, CEDRIC; DESCHATELETS, PASCAL
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 059047/0373 →
Assignment of Assignor's Interest
Mar 23, 2022
From: FRANCOIS, CEDRIC; SCHEIBLER, LUKAS
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 059380/0875 →
Assignment of Assignor's Interest
Jul 11, 2022
From: FRANCOIS, CEDRIC
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 060471/0037 →
Assignment of Assignor's Interest
Sep 30, 2022
From: HOSSBACH, MARKUS; HULTSCH, KATHRIN
To: AXOLABS GMBH
Reel/Frame 061269/0381 →
Assignment of Assignor's Interest
Sep 30, 2022
From: AXOLABS GMBH
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 061269/0476 →
Assignment of Assignor's Interest
Mar 7, 2023
From: MUELLER, CHRISTIAN; SCHEIBLER, LUKAS
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 062906/0901 →
Assignment of Assignor's Interest
Apr 5, 2023
From: METLAPALLY, RAVIKANTH; RIBEIRO, RAMIRO MAGALHAES
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 063229/0855 →
Assignment of Assignor's Interest
Nov 10, 2023
From: JPHARMA SOLUTIONS GMBH
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 065526/0340 →
Assignment of Assignor's Interest
Nov 10, 2023
From: FRANCOIS, CEDRIC; DESCHATELETS, PASCAL
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 065523/0901 →
Assignment of Assignor's Interest
Nov 10, 2023
From: BARBOUR, TARA; DESCHATELETS, PASCAL; SCHEIBLER, LUKAS
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 065525/0498 →
Assignment of Assignor's Interest
Nov 10, 2023
From: GROSSI, FEDERICO; DESCHATELETS, PASCAL; FRANCOIS, CEDRIC; VEGA, CAROLINA
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 065526/0282 →
Assignment of Assignor's Interest
Nov 10, 2023
From: JOHNSON, PATRICK
To: JPHARMA SOLUTIONS GMBH
Reel/Frame 065526/0323 →
Assignment of Assignor's Interest
Mar 1, 2024
From: SCHEIBLER, LUKAS
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 066616/0221 →
Assignment of Assignor's Interest
Mar 20, 2024
From: GROSSI, FEDERICO; DESCHATELETS, PASCAL; FRANCOIS, CEDRIC
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 066834/0009 →
Assignment of Assignor's Interest
Jun 11, 2024
From: JPHARMA SOLUTIONS GMBH
To: APELLIS PHARMACEUTICALS, INC.
Reel/Frame 067692/0387 →
Assignment of Assignor's Interest
Jun 11, 2024
From: JOHNSON, PATRICK
To: JPHARMA SOLUTIONS GMBH
Reel/Frame 067691/0931 →